Wooyoung Hur
- Molecular Biology top 5%
- Organic Chemistry top 5%
- Oncology top 10%
- Hematology top 5%
- Genetics top 5%
- Co-authors
- Nathanael S. GrayTaebo SimSheng DingEric C. PetersPeter G. SchultzDavid M. SabatiniJinhua WangSeong A. Kang
- Topics
- PI3K/AKT/mTOR signaling in cancer (6 papers)Protein Kinase Regulation and GTPase Signaling (5 papers)HER2/EGFR in Cancer Research (5 papers)
- Cited by
- Molecular BiologyHematologyGenetics
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Medicinal Chemistry
- Partner nations
- United StatesSouth KoreaJapan
In The Last Decade
Wooyoung Hur
34 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.3k
- Organic Chemistry 402
- Oncology 253
- Hematology 181
- Genetics 161
Countries citing papers authored by Wooyoung Hur
This map shows the geographic impact of Wooyoung Hur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wooyoung Hur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wooyoung Hur more than expected).
Fields of papers citing papers by Wooyoung Hur
This network shows the impact of papers produced by Wooyoung Hur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wooyoung Hur. The network helps show where Wooyoung Hur may publish in the future.
Co-authorship network of co-authors of Wooyoung Hur
This figure shows the co-authorship network connecting the top 25 collaborators of Wooyoung Hur. A scholar is included among the top collaborators of Wooyoung Hur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wooyoung Hur. Wooyoung Hur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 8 | |
| 9 | 50 | |
| 10 | 18 | |
| 11 | 25 | |
| 12 | 10 | |
| 13 | Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer | 11 |
| 14 | 66 | |
| 15 | 184 | |
| 16 | 111 | |
| 17 | 32 | |
| 18 | 290 | |
| 19 | 117 | |
| 20 | 306 |
About Wooyoung Hur
Wooyoung Hur is a scholar working on Toxicology, Molecular Biology and Hematology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Molecular Biology (1.3k citations), Hematology (181 citations) and Genetics (161 citations). Wooyoung Hur has collaborated with scholars based in United States, South Korea and Japan. Frequent co-authors include Nathanael S. Gray, Taebo Sim, Sheng Ding, Eric C. Peters, Peter G. Schultz, David M. Sabatini, Jinhua Wang, Seong A. Kang, Qingsong Liu and Carson C. Thoreen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.